InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
14
T+90 hit rate
33%
T+90 mean return
-9.0%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Versant Venture Capital VI, L.P.. Director active across 10 companies, notably LENZ Therapeutics, Inc.. In total, 33 reports have been recorded. Breakdown: 0 buy · 14 sells. Total volume traded: €32.9m. Activity tracked since 12 May 2021. The latest transaction was filed on 30 September 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations33 total
49,701 shares@ US$45.35470.38% mcap36.6% of flowCommon StockSEC:0001193125-25-228493:0
49,701 shares@ US$45.354736.6% of flowCommon StockSEC:0001193125-25-228493
307,707 shares@ US$1.533250.0% of flowCommon StockSEC:0001193125-25-207677:0
307,707 shares@ US$1.533250.0% of flowCommon StockSEC:0001193125-25-207677
20,493 shares@ US$40.02970.14% mcap13.4% of flowCommon StockSEC:0000950170-25-111529:0
20,493 shares@ US$40.029713.4% of flowCommon StockSEC:0000950170-25-111529
89,990 shares@ US$9.65937.8% of flowCommon StockSEC:0000950170-24-119051:0
1,132,566 shares@ US$6.529663.8% of flowCommon StockSEC:0000950170-24-109112:0
541,897 shares@ US$6.0028.4% of flowCommon StockSEC:0000950170-24-106532:0
221,600 shares@ US$6.3202100.0% of flowCommon StockSEC:0000950170-24-102354:0
400,000 shares@ US$1.3501100.0% of flowCommon StockSEC:0000950170-24-095675:0
391,785 sharesClass A Common StockSEC:0000899243-24-000269:0
598,203 sharesCommon StockSEC:0000950170-24-035951:0
2,236,888 sharesCommon StockSEC:0000899243-23-000677:0
550,000 shares@ US$13.0302100.0% of flowCommon StockSEC:0000899243-22-028388:0
178,996 shares0Common StockSEC:0000899243-22-004169
178,996 shares0Common StockSEC:0000899243-22-004169:0
200,213 shares0Common StockSEC:0000899243-22-001360
200,213 shares0Common StockSEC:0000899243-22-001360:0
371,004 shares0Common StockSEC:0000899243-21-049938
371,004 shares0Common StockSEC:0000899243-21-049938:0
200,213 shares0Common StockSEC:0000899243-21-049594
200,213 shares0Common StockSEC:0000899243-21-049594:0
303,614 shares@ US$14.632750.0% of flowCommon StockSEC:0000899243-21-040777:0
303,614 shares@ US$14.6327100.0% of flowCommon StockSEC:0000899243-21-040777
25 of 33 declarations
About Versant Venture Capital VI, L.P.
Versant Venture Capital VI, L.P. is an investor in LENZ Therapeutics, Inc.
